Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial
NCT02160600 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124
Last updated 2017-04-27
Summary
To compare SBDECT with standard Triple Phase Multi-Detector CT (TPMDCT) in renal mass evaluation in terms of appropriateness of treatment received after diagnosis. To determine SBDECT diagnostic accuracy.
Conditions
- Renal Cell Carcinoma
- Renal Cysts
- Transitional Cell Carcinoma
- AML
Interventions
- OTHER
-
Standard multiphase CT
- OTHER
-
split bolus Dual energy CT
Sponsors & Collaborators
-
All India Institute of Medical Sciences
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- India
Study Locations
More Related Trials
-
Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
NCT03964480 ·Status: RECRUITING
-
A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1
NCT07034508 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma
NCT02253992 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
NCT00278408 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma
NCT05245656 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma
NCT03761056 ·Status: COMPLETED ·Phase: PHASE2
-
Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults
NCT00797810 ·Status: UNKNOWN ·Phase: PHASE4
-
Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults
NCT00199082 ·Status: COMPLETED ·Phase: PHASE4
-
Circulating Tumor DNA in Peripheral T-cell Lymphomas
NCT06362148 ·Status: ACTIVE_NOT_RECRUITING
-
Fase II Study With BRB for Non-Hodgkin Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia's
NCT02371148 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing Response to Treatment in Non-Hodgkin's Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CT
NCT01598558 ·Status: WITHDRAWN ·Phase: NA
-
Whole Body PET-MRI in Paediatric and Adolescent Lymphoma
NCT02935348 ·Status: UNKNOWN
-
Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)
NCT03010176 ·Status: COMPLETED ·Phase: PHASE1
-
Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0
NCT03265158 ·Status: UNKNOWN
-
A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients
NCT02558816 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
NCT02763319 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
PET Adapted Treatment of Patients With Limited Stage DLBCL and no Risk Factors
NCT05078840 ·Status: RECRUITING
-
Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)
NCT07288814 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Phase II Study of Age-Adjusted Rituximab, Bendamustine, Cytarabine as Induction Therapy in Older Patients With MCL
NCT01662050 ·Status: COMPLETED ·Phase: PHASE2
-
Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients
NCT01516580 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia
NCT01670812 ·Status: UNKNOWN ·Phase: PHASE3
-
On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma
NCT06503211 ·Status: RECRUITING ·Phase: PHASE1
-
Maintenance Therapy With Anti-PD-1 Antibody for Patients With NK/T-cell Lymphoma
NCT04338282 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma
NCT03391466 ·Status: COMPLETED ·Phase: PHASE3
-
Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
NCT00003338 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3